Ann: Quarterly Activities Report and Appendix 4C, page-7

Interesting update with the LOAD technology in the in vitro testing. I'd have many questions regarding that experiment on whether the "mixed cell population" was an immortalized non-human species or a primary human cells, what protein:cell receptor, what approach (FISH etc.), was an affect observed. If the results are positive in a primary human cell line then the company should state that. That result would be exciting (in vitro). GFP+ cell lines can be made by almost anyone these days.
The tightening of purse strings can be evident by only $56k spent on tangibles, with the main costs associated with staffing. The staffing costs are still quite high for only 40-odd employees, I suspect staffing is difficult and wages are up to whisk expertise away from stable/safe companies.